{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:19:01Z","timestamp":1763018341396,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jacl.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T03:35:05Z","timestamp":1619667305000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical reasoning and prevention of cardiovascular disease"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3540-3956","authenticated-orcid":false,"given":"Sniderman","family":"Allan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Thanassoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jacl.2021.04.001_bib0001","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacl.2021.04.001_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamacardio.2016.0991","article-title":"Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events","volume":"1","author":"Sniderman","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"31","key":"10.1016\/j.jacl.2021.04.001_bib0003","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/eurheartj\/ehaa150","article-title":"2019 vs. 2016 ESC\/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease","volume":"41","author":"Mortensen","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1016\/j.jacl.2021.04.001_bib0004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2021.04.001_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jama.2015.6177","article-title":"The Role of Physicians in the Era of Predictive Analytics","volume":"314","author":"Sniderman","year":"2015","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.jacl.2021.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jacl.2021.04.001_bib0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med."},{"issue":"15","key":"10.1016\/j.jacl.2021.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jacl.2021.04.001_bib0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosissup.2021.01.001","article-title":"Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk","volume":"42","author":"Tokgozoglu","year":"2020","journal-title":"Atherosclerosis Supplements"},{"issue":"8983","key":"10.1016\/j.jacl.2021.04.001_bib0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(95)91850-7","article-title":"Evidence-based medicine","volume":"346","author":"Sackett","year":"1995","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.jacl.2021.04.001_bib0011","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.mayocp.2013.07.012","article-title":"The necessity for clinical reasoning in the era of evidence-based medicine","volume":"88","author":"Sniderman","year":"2013","journal-title":"Mayo Clin Proc."},{"issue":"24","key":"10.1016\/j.jacl.2021.04.001_bib0012","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: the framingham heart study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2021.04.001_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2021.04.001_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2019.04.047","article-title":"Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention","volume":"74","author":"Pencina","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1016\/j.jacl.2021.04.001_bib0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/cclm-2019-1253","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM","volume":"58","author":"Langlois","year":"2020","journal-title":"Clin Chem Lab Med."},{"issue":"5","key":"10.1016\/j.jacl.2021.04.001_bib0016","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1373\/clinchem.2012.196733","article-title":"Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices","volume":"59","author":"Cole","year":"2013","journal-title":"Clin Chem."},{"issue":"6","key":"10.1016\/j.jacl.2021.04.001_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOL.0000000000000127","article-title":"Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB","volume":"25","author":"Sniderman","year":"2014","journal-title":"Curr Opin Lipidol."},{"issue":"12","key":"10.1016\/j.jacl.2021.04.001_bib0018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"7","key":"10.1016\/j.jacl.2021.04.001_bib0019","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","article-title":"Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease","volume":"140","author":"Welsh","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2021.04.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. Rader DJ, ed","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.jacl.2021.04.001_bib0021","article-title":"High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease","author":"Zuber","year":"2020","journal-title":"Int J Epidemiol."},{"key":"10.1016\/j.jacl.2021.04.001_bib0022","unstructured":"Johannesen C.D., Mortensen M.B., Langsted A., Nordestgaard B. Apolipoprotein B and Non-HDL-C Better Reflect Residual Risk than LDL Cholesterol in Statin-Treated Patients With Atherosclerosis. J Am Coll Cardiol."},{"key":"10.1016\/j.jacl.2021.04.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.032463","article-title":"Impact of Novel LDL-C Assessment on the Utility of Secondary Non-HDL-C and ApoB Targets in Selected Worldwide Dyslipidemia Guidelines","author":"Sathiyakumar","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2021.04.001_bib0024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.jacl.2021.04.001_bib0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamacardio.2018.1533","article-title":"Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin\/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial","volume":"3","author":"Martin","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jacl.2021.04.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2021.02.009","article-title":"Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population","author":"Piani","year":"2021","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.jacl.2021.04.001_bib0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cca.2020.05.001","article-title":"The clinical utility of apoB versus LDL-C\/non-HDL-C","volume":"508","author":"Kohli-Lynch","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.jacl.2021.04.001_bib0028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol."},{"issue":"13","key":"10.1016\/j.jacl.2021.04.001_bib0029","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.117.031855","article-title":"Quantifying Importance of Major Risk Factors for Coronary Heart Disease","volume":"139","author":"Pencina","year":"2019","journal-title":"Circulation"},{"issue":"9753","key":"10.1016\/j.jacl.2021.04.001_bib0030","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"may21 5","key":"10.1016\/j.jacl.2021.04.001_bib0031","doi-asserted-by":"crossref","first-page":"g3047","DOI":"10.1136\/bmj.g3047","article-title":"Taking a longer term view of cardiovascular risk: the causal exposure paradigm","volume":"348","author":"Sniderman","year":"2014","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.jacl.2021.04.001_bib0032","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease","volume":"133","author":"Thanassoulis","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacl.2021.04.001_bib0033","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jamacardio.2018.3476","article-title":"A long-term benefit approach vs standard risk-based approaches for statin eligibility in primary prevention","volume":"3","author":"Thanassoulis","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"9","key":"10.1016\/j.jacl.2021.04.001_bib0034","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"Pencina","year":"2020","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:51Z","timestamp":1761831411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1933287421000593"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.04.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical reasoning and prevention of cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}